x

Join Advarra

Learn more about our company team, careers, and values. Join Advarra’s Talented team to take on engaging work in a dynamic environment.

See Jobs

Luke Gelinas, PhD

Senior IRB Chair Director, Advarra

Luke Gelinas is the Senior IRB Chair Director at Advarra, where he provides analysis and guidance on complex ethical issues arising in the course of clinical research study design and human participant protection. Previously, Luke led collaborative and multi-stakeholder projects addressing foundational and practical issues in research ethics including social media use, clinical trial priority-setting, and has explored the ethical and regulatory parameters paying research participants. His written work has appeared in leading medical and bioethics journals, and frequently lectures on various issues surrounding research ethics and human participant protection. Luke holds a PhD in Philosophy with a concentration in Ethics from the University of Toronto and an MA in Religion from Yale Divinity School.

Luke Gelinas

Latest Posts by Luke

 
Blog

New FDA Certificate of Confidentiality Guidance: What Does it Mean for You?

Certificates of Confidentiality protect participant privacy by preventing disclosed sensitive information during research.

Read Now
4 min. read
Read more
 
Blog

The Many Faces of “Coercion” and “Undue Influence”

Coercion and undue influence in research can be complicated. Understand what these terms mean and how to appropriately protect against them.

Read Now
5 min. read
Read more
 
Webinar

Evaluating Payment to Participate in Research: Ethical and Regulatory Issues

In this webinar, Luke Gelinas, IRB Chairperson at Advarra, proposes a practical framework for evaluating offers of payment and applies it to case studies to yield guidance on challenging ethical and regulatory issues involved in paying research subjects.

Watch Now
Read more
 
Blog

Patient Engagement and the IRB

With increased efforts to engage and include patient and participant communities more closely in research, when does an IRB review become required?

Read Now
4 min. read
Read more
 
Blog

Trial Design in the Time of COVID-19: Complex and Efficient

Complex trial designs can eliminate less-promising investigational treatments quickly to speed development, but they remain under-utilized. Read more:

Read Now
4 min. read
Read more
 
Blog

Differentiating “Public” and “Private” Internet Spaces in IRB Review

The difference between “public” and “private” internet spaces has gained importance with the growing research use of internet and social media platforms as data sources. Read more:

Read Now
4 min. read
Read more
 
Blog

Q&A Part 1 – Evaluating Payment to Participate in Research: Ethical and Regulatory Issues

Dr. Gelinas answers audience questions we weren’t able to address during the webinar.

Read Now
6 min. read
Read more
 
Blog

Should Social Media Be Part of Your Research Toolbox?

Social media has emerged as a valuable tool for diverse stakeholders across the research community. Learn about the risks and benefits in this article.

Read Now
5 min. read
Read more
 
Webinar

Oversight Challenges with Patient Centered Outcomes Research

In this webinar, Luke Gelinas, PhD, IRB Chair at Advarra, lays out some of the oversight challenges raised by PCOR.

Watch Now
Read more